Pfizer and BioNTech began late-stage human trial for coronavirus vaccine Monday – CNBC

U.S. drugmaker Pfizer and German biotech BioNTech stated they began their late-stage human trial for a prospective coronavirus vaccine on Monday as pharmaceutical business race to win regulatory approva … [+3135 chars]